{
    "2018-10-24": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Galapagos and AbbVie Restructure CF Collaboration",
                "features": {
                    "keywords": [
                        "Galapagos",
                        "AbbVie",
                        "Restructure",
                        "CF",
                        "Collaboration"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AbbVie Inc. of Class Action Lawsuit and Upcoming Deadline â€“ ABBV",
                "features": {
                    "keywords": [
                        "SHAREHOLDER",
                        "ALERT",
                        "Pomerantz",
                        "Law",
                        "Firm",
                        "Class",
                        "Action",
                        "Lawsuit",
                        "AbbVie"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "legal",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "AbbVie to Assume Full Development and Commercial Control of Cystic Fibrosis Research Program",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Full",
                        "Development",
                        "Commercial",
                        "Control",
                        "Cystic",
                        "Fibrosis",
                        "Research",
                        "Program"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Galapagos and AbbVie restructure CF collaboration",
                "features": {
                    "keywords": [
                        "Galapagos",
                        "AbbVie",
                        "restructure",
                        "CF",
                        "collaboration"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",
                "features": {
                    "keywords": [
                        "SHAREHOLDER",
                        "NOTICE",
                        "Schall",
                        "Law",
                        "Firm",
                        "Class",
                        "Action",
                        "Lawsuit",
                        "AbbVie"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "legal",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "AbbVie Falls 3%",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Falls",
                        "3%"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Healthcare ETFs to Buy Ahead of Q3 Earnings",
                "features": {
                    "keywords": [
                        "Healthcare",
                        "ETFs",
                        "Buy",
                        "Q3",
                        "Earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "3 Healthcare Stocks I'd Buy Right Now",
                "features": {
                    "keywords": [
                        "Healthcare",
                        "Stocks",
                        "Buy",
                        "Right",
                        "Now"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "The Daily Biotech Pulse: Illumina's Strong Q3, Celgene's Positive Cancer Drug Trial, Proteostasis Offering",
                "features": {
                    "keywords": [
                        "Daily",
                        "Biotech",
                        "Pulse",
                        "Illumina",
                        "Strong",
                        "Q3",
                        "Celgene",
                        "Positive",
                        "Cancer",
                        "Drug",
                        "Trial",
                        "Proteostasis",
                        "Offering"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "3 Healthcare Stocks I'd Buy Right Now",
                "features": {
                    "keywords": [
                        "Healthcare",
                        "Stocks",
                        "Buy",
                        "Right",
                        "Now"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-12",
                "original_text": "AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Dips",
                        "Broader",
                        "Markets"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}